Study of BR1015-A and its components under fed conditions
Part of Heart & circulation clinical trials.
This trial tests a new medicine called BR1015-A. It compares how the body handles the medicine when given alone versus as two separate parts taken together. The study is done after eating to see how food affects the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old (or the typical adult range, check with the study team).
- You must have a body mass index (BMI) between 18.0 and 30.0 kg/m².
- You must be generally healthy, without major medical problems.
- You must not be pregnant or breastfeeding, and if you or your partner can have children, you must agree to use effective birth control (not hormonal) during the study and for 14 days after the last dose.
- You cannot have taken certain medications or supplements in the last 10 to 30 days (the study team will check this).
- You must not have had stomach or intestinal surgery (except simple appendix or hernia surgery) or have a condition that affects drug absorption.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the body processes a new drug combination (BR1015-A vs. BR1015-3 and BR1015-2 taken together) in healthy volunteers. It helps researchers understand the safety and drug levels in the blood when taken on an empty stomach.
This trial tests a new drug, BR1015, to see how it moves through the body and if it is safe. It is for healthy adults who are willing to fast before taking the medicine.
This trial tests a new medicine (BR1015-A) taken with food and compares it to taking two other medicines together. It is for healthy volunteers to see how the drug moves through the body and if it is safe.
This trial tests five new medications to see how well they lower blood pressure in people with essential hypertension (high blood pressure with no known cause). Participants will temporarily stop their current blood pressure medicine during the study.
This trial tests the safety of a new drug called BCD101 in healthy people. It checks how the drug moves through the body and if it causes any side effects.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
Hear when a new Essential Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.